List of Excipients in API OXAPROZIN
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing OXAPROZIN
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | CELLULOSE, MICROCRYSTALLINE | |
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | HYPROMELLOSE | |
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | METHYLCELLULOSE | |
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | POLACRILIN POTASSIUM | |
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | POLYETHYLENE GLYCOL | |
| Pfizer Laboratories Div Pfizer Inc | DAYPRO | oxaprozin | 0025-1381 | TITANIUM DIOXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing OXAPROZIN
Detailed excipient profiles for OXAPROZIN
Excipient focus: CARNAUBA WAX
OXAPROZIN drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | oxaprozin | 0093-0924 |
| Rebel Distributors Corp | oxaprozin | 21695-100 |
| PD-Rx Pharmaceuticals Inc | oxaprozin | 55289-601 |
| Bryant Ranch Prepack | oxaprozin | 63629-1345 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
OXAPROZIN drug variants containing CELLULOSE, MICROCRYSTALLINE
OXAPROZIN drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | oxaprozin | 62135-176 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
OXAPROZIN drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | oxaprozin | 62135-176 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C YELLOW NO. 10
OXAPROZIN drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | oxaprozin | 16590-178 |
| HJ Harkins Company Inc | oxaprozin | 52959-800 |
| Dr Reddy's Laboratories Limited | oxaprozin | 55111-170 |
| ST MARY'S MEDICAL PARK PHARMACY | oxaprozin | 60760-382 |
| California Pharmaceuticals LLC | oxaprozin | 70332-310 |
| Bryant Ranch Prepack | oxaprozin | 71335-0393 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C YELLOW NO. 6
OXAPROZIN drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | oxaprozin | 16590-178 |
| HJ Harkins Company Inc | oxaprozin | 52959-800 |
| Dr Reddy's Laboratories Limited | oxaprozin | 55111-170 |
| ST MARY'S MEDICAL PARK PHARMACY | oxaprozin | 60760-382 |
| California Pharmaceuticals LLC | oxaprozin | 70332-310 |
| Bryant Ranch Prepack | oxaprozin | 71335-0393 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROXYPROPYL CELLULOSE
OXAPROZIN drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | oxaprozin | 62135-176 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
OXAPROZIN drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | oxaprozin | 0025-1381 |
| Eon Labs Inc | oxaprozin | 0185-0141 |
| PD-Rx Pharmaceuticals Inc | oxaprozin | 55289-453 |
| Greenstone LLC | oxaprozin | 59762-6002 |
| DIRECT RX | oxaprozin | 61919-673 |
| Chartwell RX LLC | oxaprozin | 62135-176 |
| Bryant Ranch Prepack | oxaprozin | 63629-8724 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
OXAPROZIN drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | oxaprozin | 0093-0924 |
| PD-Rx Pharmaceuticals Inc | oxaprozin | 55289-601 |
| Bryant Ranch Prepack | oxaprozin | 63629-1345 |
| Solubiomix LLC | oxaprozin | 69499-403 |
| Ayurax LLC | oxaprozin | 73308-403 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
OXAPROZIN drug variants containing HYPROMELLOSES
OXAPROZIN drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
OXAPROZIN drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | oxaprozin | 16590-178 |
| HJ Harkins Company Inc | oxaprozin | 52959-800 |
| Dr Reddy's Laboratories Limited | oxaprozin | 55111-170 |
| ST MARY'S MEDICAL PARK PHARMACY | oxaprozin | 60760-382 |
| California Pharmaceuticals LLC | oxaprozin | 70332-310 |
| Bryant Ranch Prepack | oxaprozin | 71335-0393 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
OXAPROZIN drug variants containing MAGNESIUM STEARATE
OXAPROZIN drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Solubiomix LLC | oxaprozin | 69499-403 |
| Ayurax LLC | oxaprozin | 73308-403 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLCELLULOSE
OXAPROZIN drug variants containing METHYLCELLULOSE
OXAPROZIN drug variants not containing METHYLCELLULOSE
Excipient focus: POLACRILIN POTASSIUM
OXAPROZIN drug variants containing POLACRILIN POTASSIUM
OXAPROZIN drug variants not containing POLACRILIN POTASSIUM
Excipient focus: POLYDEXTROSE
OXAPROZIN drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | oxaprozin | 16590-178 |
| HJ Harkins Company Inc | oxaprozin | 52959-800 |
| Dr Reddy's Laboratories Limited | oxaprozin | 55111-170 |
| ST MARY'S MEDICAL PARK PHARMACY | oxaprozin | 60760-382 |
| California Pharmaceuticals LLC | oxaprozin | 70332-310 |
| Bryant Ranch Prepack | oxaprozin | 71335-0393 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
OXAPROZIN drug variants containing POLYETHYLENE GLYCOL
OXAPROZIN drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
OXAPROZIN drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | oxaprozin | 0093-0924 |
| PD-Rx Pharmaceuticals Inc | oxaprozin | 55289-601 |
| Bryant Ranch Prepack | oxaprozin | 63629-1345 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOLS
OXAPROZIN drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| Dispensing Solutions Inc | oxaprozin | 66336-722 |
| California Pharmaceuticals LLC | oxaprozin | 70332-310 |
| California Pharmaceutical LLC | oxaprozin | 70332-311 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
OXAPROZIN drug variants containing POLYSORBATE 80
OXAPROZIN drug variants not containing POLYSORBATE 80
Excipient focus: SILICON DIOXIDE
OXAPROZIN drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eon Labs Inc | oxaprozin | 0185-0141 |
| St Mary's Medical Park Pharmacy | oxaprozin | 60760-203 |
| DIRECT RX | oxaprozin | 61919-673 |
| Chartwell RX LLC | oxaprozin | 62135-176 |
| Bryant Ranch Prepack | oxaprozin | 63629-8724 |
| Dispensing Solutions Inc | oxaprozin | 66336-722 |
| Carilion Materials Management | oxaprozin | 68151-0523 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
OXAPROZIN drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Solubiomix LLC | oxaprozin | 69499-403 |
| Ayurax LLC | oxaprozin | 73308-403 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
OXAPROZIN drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
OXAPROZIN drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
OXAPROZIN drug variants containing STARCH, CORN
OXAPROZIN drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | oxaprozin | 0025-1381 |
| PD-Rx Pharmaceuticals Inc | oxaprozin | 55289-453 |
| Greenstone LLC | oxaprozin | 59762-6002 |
| Chartwell RX LLC | oxaprozin | 62135-176 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
OXAPROZIN drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | oxaprozin | 62135-176 |
| Solubiomix LLC | oxaprozin | 69499-403 |
| Ayurax LLC | oxaprozin | 73308-403 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing STEARIC ACID
Excipient focus: TITANIUM DIOXIDE
OXAPROZIN drug variants containing TITANIUM DIOXIDE
OXAPROZIN drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Solubiomix LLC | oxaprozin | 69499-403 |
| Ayurax LLC | oxaprozin | 73308-403 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
OXAPROZIN drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | oxaprozin | 16590-178 |
| HJ Harkins Company Inc | oxaprozin | 52959-800 |
| Dr Reddy's Laboratories Limited | oxaprozin | 55111-170 |
| ST MARY'S MEDICAL PARK PHARMACY | oxaprozin | 60760-382 |
| California Pharmaceuticals LLC | oxaprozin | 70332-310 |
| Bryant Ranch Prepack | oxaprozin | 71335-0393 |
| >Company | >Ingredient | >NDC |
OXAPROZIN drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
